People: Bovie Medical Corp (BVX)

BVX on American Stock Exchange

3.94USD
30 Oct 2014
Price Change (% chg)

$0.02 (+0.51%)
Prev Close
$3.92
Open
$4.00
Day's High
$4.00
Day's Low
$3.94
Volume
4,890
Avg. Vol
17,997
52-wk High
$5.00
52-wk Low
$1.94

Search Stocks

Summary

Name Age Since Current Position

Andrew Makrides

72 2013 Executive Chairman of the Board

J. Robert Saron

61 2011 President, Chief Sales and Marketing Officer, Director

Robert Gershon

47 2013 Chief Executive Officer, Director

Peter Donato

44 2014 Chief Financial Officer, Executive Vice President, Treasurer, Secretary

Moshe Citronowicz

61 2011 Senior Vice President

Jack McCarthy

47 2014 Chief Commercialization Officer

Michael Geraghty

66 2011 Independent Director

Ian Sheffield

37 2013 Independent Director

Lawrence Waldman

67 2011 Independent Director

Biographies

Name Description

Andrew Makrides

Mr. Andrew Makrides, Esq., is an Executive Chairman of the Board of Bovie Medical Corp. He received a Bachelor of Arts degree in Psychology from Hofstra University and a Juris Doctor Degree from Brooklyn Law School. He is a member of the Bar of the State of New York and practiced law from 1968 until joining Bovie Medical Corporation as a co-founder and Executive Vice President and director, in 1982. Mr. Makrides became President of the Company in 1985 and the CEO in December 1998 and has served as such until March 18, 2011 at which point he relinquished his position as President, but remained CEO until December 2013. Mr. Makrides employment contract extends to December 31, 2016. Mr. Makrides has over 29 years of executive experience in the medical industry.

J. Robert Saron

Mr. J. Robert Saron is President, Chief Sales and Marketing Officer, Director of Bovie Medical Corp. He holds a Bachelor degree in Social and Behavioral Science from the University of South Florida. From 1988 to present Mr. Saron has served as a director of the Company. Mr. Saron currently serves on an industry board as a director of the Health Industry Distributors Association Education Foundation. He previously served as both director and president of the Healthcare Manufacturers Management Council. Mr. Saron has received multiple industry awards. In 2008, Mr. Saron received the Health Industry Distributors Association’s highest award, the Industry Award of Distinction. In 2011, HMMC awarded Mr. Saron the Leonard Berke Achievement Award for ethics, mentoring, marketing skills, industry knowledge, and contributions to the industry and HMMC. Most recently, in February 2013, Mr. Saron was inducted into the Medical Distribution Hall of Fame.

Robert Gershon

Mr. Robert L. Gershon is Chief Executive Officer, Director of Bovie Medical Corp. Mr. Gershon has over 25 years of healthcare industry experience. On the operations side he ran the largest sales and marketing business at Covidien (NYSE:COV). With over $1B in P&L responsibility, he consistently led an organization of over 600 people to double-digit revenue growth, outpacing market category growth and capturing significant market share points during challenging healthcare economic conditions. He also was VP of sales and marketing at Henry Schein ($1.4B shared P&L for medical division/$115M full P&L for dialysis division) and earlier in his career spent over 13 years as a healthcare consultant for Booz, Allen, KPMG and two boutique consultancies where his practice focused on strategic planning, business development and mergers and acquisitions. Mr. Gershon received an MBA from J.L. Kellogg Graduate School of Management at Northwestern University and a BSBA degree from American University.

Peter Donato

Mr. Peter L. Donato is Chief Financial Officer, Executive Vice President, Treasurer, Secretary of Bovie Medical Corp. Mr. Donato has over 22 years of financial management and accounting experience in roles of increasing responsibility, primarily in the healthcare industry. Mr. Donato was appointed the Company’s Chief Financial Officer, Executive Vice President, Treasurer and Secretary effective May 5, 2014. For the past 10 years, he has been focused on the healthcare industry. From July 2011 to March 2013, Mr. Donato served as the Corporate Controller for Cyberonics, Inc. (NASDAQ: CYBX). Prior to that, from August 2010 to July 2011 Mr. Donato served as the Chief Financial Officer of Catsys Health, Inc. (OTCBB: CATS). From August 2007 to March 2010, Mr. Donato served as Chief Financial Officer for IRIS International, Inc. (NASDAQ: IRIS). Mr. Donato is a graduate of The Ohio State University, where he obtained a B.S./B.A. degree in Accounting in 1992 and earned an MBA from The University of Akron in 1999. Mr. Donato received his CPA license in 1995.

Moshe Citronowicz

Mr. Moshe Citronowicz is Senior Vice President of Bovie Medical Corporation. He is Senior Vice President came to the United States in 1978, and has worked in a variety of manufacturing and high technology industries. In October 1993, Mr. Citronowicz joined the Company as Vice President of Operations and served as our Chief Operating Officer until November 2011. Currently, he is serving as the Senior Vice President.

Jack McCarthy

Mr. Jack McCarthy is Chief Commercialization Officer of Bovie Medical Corp. Mr. McCarthy has 23 years of sales and marketing experience of which the last 16 years has been spent in the healthcare industry. Most recently, he served as Vice President of Sales and Marketing for US Healthcare at Z-Medica. Prior to that, Mr. McCarthy spent 15 years with Covidien (NYSE:COV), in positions of increasing responsibility where he was charged with achieving sales and business development goals. His most recent position at Covidien was as Area Sales Vice President for the Endo Mechanical Intelligent Device franchise, where he managed a team of 50 sales professionals. Mr. McCarthy is a graduate of Loyola College in Baltimore, Maryland, where he obtained a BA degree in Marketing in 1988 and an MBA in Marketing in 1990.

Michael Geraghty

Mr. Michael E. Geraghty is Independent Director of Bovie Medical Corporation. He has served as a director since March 2011 and is the Executive Vice President of Global Sales at Optos, Inc., a developer and manufacturer of retinal imaging devices for screening, detection and diagnosis of eye related conditions. From 2005 through 2008, he was the President of International Sales at Gyrus Acmi where he first started in 2000 as Senior Vice President of Sales for Gyrus Medical. Prior to this, Mr. Geraghty was the Vice President of Sales and Marketing for Everest Medical, Inc. and before that was the Director of Marketing for Advanced Products at Arthrocare Corporation. Mr. Geraghty specializes in building independent direct sales teams in the medical device industry and has extensive domestic and international sales and marketing experience. He received his bachelor’s degree from St. Mary’s University and graduate degree in Executive Sales Management from the University of Minnesota.

Ian Sheffield

Mr. Ian D. Sheffield is Independent Director of Bovie Medical Corp.He joined the Board in December 2013 as an initial nominee of Great Point Partners, LLC and currently serves as a Vice President at Great Point Partners in Greenwich, CT. As part of his investment functions, he leads Great Point Partners' medical devices and diagnostics investing efforts in public companies. From 2008 through 2011, prior to joining Great Point, he served in various capacities at Versant Ventures, and prior to 2011 at Medtronic, and Procter & Gamble. He holds a B.S. from Miami University and an M.B.A. from the Harvard Business School and also serves as a member of our Audit Committee.

Lawrence Waldman

Mr. Lawrence J. Waldman, CPA, is Independent Director of Bovie Medical Corporation. He has served as a director since March 2011 and is a certified public accountant. Mr. Waldman is currently the Partner-in-Charge of Commercial Audit Practice Development of the accounting firm EisnerAmper LLP. He has over forty years of experience in public accounting as an audit partner serving a wide range of clients. Prior to joining EisnerAmper LLP, Mr. Waldman was the Partner-in-Charge of Commercial Audit Practice Development for Holtz Rubenstein Reminick, LLP. Mr. Waldman was the Managing Partner of the Long Island office of KPMG LLP from 1994 through 2006, the accounting firm where he started at in 1972. Mr. Waldman is a former Chairman of the Board of Trustees of the Long Island Power Authority and served on the Finance and Audit Committee of the Board of Trustees. He is currently the Treasurer of the Long Island Association as well as a member of its Board of Directors and Chairman of the Finance Committee. In addition, Mr. Waldman is a member of the Board of Directors and Treasurer of each of the Long Island Angel Network and the Advanced Energy Research Center at Stony Brook University and a member of the Dean’s Advisory Board of the Hofstra University Frank G. Zarb School of Business. Mr. Waldman currently serves as a member of the Supervisory Committee of The Bethpage Federal Credit Union. Mr. Waldman received his bachelor’s degree and MBA from Hofstra University where he is also an adjunct professor.

Basic Compensation

Name Fiscal Year Total

Andrew Makrides

231,308

J. Robert Saron

325,741

Robert Gershon

629,102

Peter Donato

--

Moshe Citronowicz

219,582

Jack McCarthy

--

Michael Geraghty

--

Ian Sheffield

--

Lawrence Waldman

--
As Of 30 Dec 2013

Options Compensation

Name Options Value

Andrew Makrides

882,900 6,531,250

J. Robert Saron

650,400 4,422,480

Robert Gershon

0 0

Peter Donato

0 0

Moshe Citronowicz

517,900 4,290,050

Jack McCarthy

0 0

Michael Geraghty

0 0

Ian Sheffield

0 0

Lawrence Waldman

0 0
Search Stocks